Sacral Neuromodulation Market Share To 2020- 2027

About This Presentation
Title:

Sacral Neuromodulation Market Share To 2020- 2027

Description:

The study segments the Sacral Neuromodulation industry in light of major classification such as product type, potential markets, application, and end-user. – PowerPoint PPT presentation

Number of Views:8

less

Transcript and Presenter's Notes

Title: Sacral Neuromodulation Market Share To 2020- 2027


1
Sacral Neuromodulation Market To Reach USD 3153.4
Million By 2026
2
Increasing elderly population, rise in the
neurological diseases as well as failure of
conventional treatments (exercise, changes in
lifestyle, diet) to cure SNM expiries are key
factors contributing to high CAGR of Sacral
Neuromodulation during forecast period.Market
Size USD 2189.1 million in 2018, Market Growth
- CAGR of 4.94, Market Trends Product launches
and research for Sacral neuromodulationAccording
to the current analysis of Reports and Data, the
global Sacral neuromodulation market was valued
at USD 2189.1 million in 2018 and is expected to
reach USD 3153.4 million by year 2026, at a CAGR
of 4.94 . The study covers in-depth analysis of
Sacral Neuromodulation and the treatments to cure
it. Overactive bladder symptoms of urgency,
frequency and incontinency is at present
affecting a significant amount of population,
especially when age increases. Sacral
Neuromodulation (also known as sacral nerve
stimulation) has been one of the popular and
effective treatment options to cure overactive
bladder and bowel problems for more than last 2
decades. The main purpose of the Sacral Neuro
modulation is to improve the coordination between
bladder/bowel and our brain. One of the proven
treatments include sacral neuromodulation via the
interstim system. The procedure is divided into
two main stages which include basic evaluation
and advanced evaluation. In both the evaluations
a portable, external stimulator which generates
stimulations is delivered through a lead.
Market Summary
www.reportsanddata.com
3
  • Further key findings from the report suggest
  • North America is the largest revenue generating
    region in the global Sacral neuromodulation
    market. It holds 35.5 of the total market share
    owing to the technological advancements and
    rising awareness about SNM. Followed by that,
    Europe accounts for 31.2 of the total market
    share.
  • Implantable SNM devices in comparison to external
    SNM devices is a more popular option on a global
    level. It holds 62.5 of the total market share
    whereas External SNM device holds 33.3 of the
    total market share.
  • Welkin Health, a privately-held patient
    relationship management software company has
    recently announced that it will be collaborating
    with Axonics Modulation Technologies in finding
    new solutions for SNM.
  • With only a handful of players in the market,
    there are tremendous opportunities for companies
    like Axonics to enter in the market.
  • Revenue from the sale of SNM devices is estimated
    to be rise around USD 600 million annually with
    nearly 30,000 devices implanted in patients in
    2014 alone.
  • Revenue for this market is estimates to grow to
    over USD1 billion by the end of 2019.
  • According to a US-based study, overactive bladder
    (OAB) symptoms are prevalent in 17 males and
    17.9 in female population in US.
  • In case of Europe, 16 men and 17.8 women above
    40 years of age were estimated to have OAB
    symptoms in the coming years.
  • Associated side effects related to SNM treatments
    and lack of awareness about Sacral
    neuromodulation is likely to hinder the market
    growth during the forecast period.
  • To look at the PDF Sample Report and get
    30 minutes of a free consultation _at_
    https//www.reportsanddata.com/sample-enquiry-form
    /1487

4
Market Summary
  • Key Players
  • Cyberonics, St Jude Medicals, Boston Scientific,
    Medtronic.
  • Segmentation
  • For the purpose of this study, Reports and Data
    have segmented the Sacral neuromodulation market
    on the basis of product, application, and region
  • Product (Revenue, USD Million 20162026)
  • Implantable SNM devices
  • External SNM devices
  • Application (Revenue, USD Million 20162026)
  • Urinary incontinence
  • Urge incontinence
  • Regional Outlook (Revenue in USD Million
    20162026)
  • North America
  • Europe
  • Asia Pacific
  • Middle East Africa
  • Latin America
  • Grab Your Report at an
    Impressive Discount! Please Click Here
    https//www.reportsanddata.com/discount-enquiry-fo
    rm/1487

www.reportsanddata.com
5
The report emphasizes the following key
questions
Q.1.What are the most lucrative and promising
growth prospects for the market? Q.2.Which
sectors are expected to deliver a high growth
rate and which industry aspects come into play in
this advancement? Q.3.Which geographies are
estimated to exhibit the highest growth and the
underlying causes? Q.4.Which factors are
impacting the future of the market and what are
the driving factors? Q.5.What are the hurdles
and challenges curtailing the industrys growth
in the forecast period?
www.reportsanddata.com
6
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer market
intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact Us John Watson Head of Business
Development Reports And Data Web
www.reportsanddata.com Direct Line
1-212-710-1370 E-mail sales_at_reportsanddata.com
Write a Comment
User Comments (0)